ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.010
-0.040 (-1.31%)
May 28, 2026, 4:08 PM HKT
-71.60% (1Y)
| Market Cap | 1.32B -51.3% |
| Revenue (ttm) | 171.70M +94.0% |
| Net Income | -243.24M |
| EPS | -0.59 |
| Shares Out | 431.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,119,400 |
| Open | 3.050 |
| Previous Close | 3.050 |
| Day's Range | 2.920 - 3.060 |
| 52-Week Range | 2.950 - 16.800 |
| Beta | 0.41 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 2, 2026 |